Perrigo Company plc (Ireland) (PRGO)
NYSE · Common · CUSIP 714290103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PRGO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
714290103
Market Cap
Large Cap · $7 Billion
Previous Name
Perrigo Company
Business: Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.
Notes: DUBLIN, Dec. 18, 2013 -- Perrigo Company plc (NYSE, TASE: PRGO) and Elan Corporation, plc today announced that Perrigo has completed the acquisition of Elan in a cash and stock transaction valued on the date of the announcement at approximately US$8.6 billion. In connection with the acquisition, Perrigo Company and Elan have been combined under a new company incorporated in Ireland and have adopted the global name Perrigo Company plc. Shares of Perrigo will trade on the New York Stock Exchange and the Tel Aviv Stock Exchange under the ticker symbol PRGO. _________________ May 23, 2013 -- Perrigo Company (Nasdaq: PRGO) today announced that it is transferring the listing of its U.S. traded common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Select Market (NASDAQ). The Company expects to begin trading on the NYSE on June 6, 2013 under its current stock symbol PRGO and will continue to trade on NASDAQ until the transfer takes place.

Company Contact

CEO
Murray S. Kessler
CFO
Raymond Silcock
IR
Brad Joseph 269-686-3373
Investor Relations
Bradley Joseph · 269-686-3373 · bradley.joseph@perrigo.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »